8 studies found for:    PF-04360365
Show Display Options
Rank Status Study
1 Completed Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 1 mg/kg;   Biological: PF-04360365 3 mg/kg;   Biological: PF-04360365 5 mg/kg;   Biological: PF-04360365 10 mg/kg
2 Completed Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 0.1 mg/kg;   Biological: PF-04360365 0.5 mg/kg;   Biological: PF-04360365 1 mg/kg;   Drug: Placebo;   Biological: PF-04360365 3 mg/kg;   Biological: PF-04360365 8.5 mg/kg
3 Completed Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 8.5 mg/kg;   Drug: Placebo
4 Completed A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365;   Drug: Placebo
5 Completed Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365;   Drug: Placebo
6 Completed A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365;   Drug: Placebo
7 Completed A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 10 mg/kg;   Biological: PF-04360365 7.5 mg/kg;   Drug: placebo
8 Recruiting Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy
Condition: Cerebral Amyloid Angiopathy
Interventions: Biological: Ponezumab;   Other: placebo

Indicates status has not been verified in more than two years